Pharmacologic Treatment of Chronic Constipation

• Published in: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi Vol. 83; no. 5; p. 184
• Main Authors: Wang, Hoyoung, Lee, Jung Won
• Format: Journal Article
• Language: Korean
• Published: Korea (South) 25.05.2024
• Subjects: Chronic Disease; Constipation - drug therapy; Constipation - therapy; Dietary Fiber - therapeutic use; Humans; Laxatives - therapeutic use; Laxatives; Constipation; Treatment
• ISSN: 2233-6869
• DOI: 10.4166/kjg.2024.045

Chronic constipation is a common disease that can impair the quality of life, with a prevalence of 14% globally and 16.5% in South Korea. Straining, hard stools, the sensation of incomplete evacuation, the sensation of anorectal blockage, and manual maneuvers to facilitate defecation are the related symptoms of chronic constipation. On the other hand, medications commonly referred to as laxatives are the essentials of treatment for constipation compared to non-pharmacological treatment, such as lifestyle modifications, biofeedback, or surgery. Unfortunately, there is still an unmet need to determine if pharmacological treatment for constipation is being administered appropriately. Therefore, there are many disadvantages as to whether the indications and side effects of laxatives are adequately considered and prescribed as the primary treatment modality for constipation in a real clinical situation in Korea. Laxatives are generally recommended as the next step for patients in whom organic causes have been excluded and have not responded to initial non-pharmacologic therapies such as dietary fiber intake and exercise. Laxatives can be classified as bulk-forming laxatives, osmotic laxatives, stimulant laxatives, and other novel laxatives. On the other hand, there are distinct mechanisms underlying constipation, and appropriate administration is the most decisive. Therefore, the present investigators prepared this review to discuss appropriate pharmacological strategies for chronic constipation in Korea. Moreover, this paper also includes suggestions for appropriate pharmacological treatment options for special patient populations.